annual net income:
$709.37M-$287.83M(-28.86%)Summary
- As of today (August 16, 2025), TAK annual net profit is $709.37 million, with the most recent change of -$287.83 million (-28.86%) on March 1, 2025.
- During the last 3 years, TAK annual net income has fallen by -$1.34 billion (-65.37%).
- TAK annual net income is now -80.00% below its all-time high of $3.55 billion, reached on March 31, 2021.
Performance
TAK Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$860.12M+$1.54B(+227.15%)Summary
- As of today (August 16, 2025), TAK quarterly net profit is $860.12 million, with the most recent change of +$1.54 billion (+227.15%) on June 1, 2025.
- Over the past year, TAK quarterly net income has increased by +$248.55 million (+40.64%).
- TAK quarterly net income is now -53.71% below its all-time high of $1.86 billion, reached on March 31, 2021.
Performance
TAK quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$957.25M+$248.55M(+35.07%)Summary
- As of today (August 16, 2025), TAK TTM net profit is $957.25 million, with the most recent change of +$248.55 million (+35.07%) on June 1, 2025.
- Over the past year, TAK TTM net income has dropped by -$17.36 million (-1.78%).
- TAK TTM net income is now -78.34% below its all-time high of $4.42 billion, reached on September 30, 2021.
Performance
TAK TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TAK Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.9% | +40.6% | -1.8% |
| 3 y3 years | -65.4% | +6.3% | -41.5% |
| 5 y5 years | +74.1% | +12.1% | -14.4% |
TAK Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.7% | at low | at high | +227.2% | -59.0% | +35.1% |
| 5 y | 5-year | -80.0% | +74.1% | -53.7% | +227.2% | -78.3% | +82.3% |
| alltime | all time | -80.0% | +154.5% | -53.7% | +145.5% | -78.3% | +175.7% |
TAK Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $860.12M(-227.1%) | $957.25M(+35.1%) |
| Mar 2025 | $709.37M(-28.9%) | -$676.47M(-532.5%) | $708.70M(-48.1%) |
| Dec 2024 | - | $156.42M(-74.7%) | $1.37B(-29.0%) |
| Sep 2024 | - | $617.19M(+0.9%) | $1.92B(+97.4%) |
| Jun 2024 | - | $611.56M(-3132.8%) | $974.61M(-3.8%) |
| Mar 2024 | $997.20M(-57.4%) | -$20.16M(-102.8%) | $1.01B(-20.1%) |
| Dec 2023 | - | $715.05M(-315.5%) | $1.27B(-9.1%) |
| Sep 2023 | - | -$331.84M(-151.0%) | $1.40B(-35.8%) |
| Jun 2023 | - | $650.07M(+176.4%) | $2.17B(-6.8%) |
| Mar 2023 | $2.34B(+14.2%) | $235.16M(-72.1%) | $2.33B(+16.6%) |
| Dec 2022 | - | $842.54M(+88.8%) | $2.00B(+20.1%) |
| Sep 2022 | - | $446.26M(-44.8%) | $1.67B(+1.7%) |
| Jun 2022 | - | $808.86M(-927.1%) | $1.64B(-21.6%) |
| Mar 2022 | $2.05B(-42.3%) | -$97.80M(-119.2%) | $2.09B(-48.4%) |
| Dec 2021 | - | $508.42M(+21.7%) | $4.04B(-8.5%) |
| Sep 2021 | - | $417.80M(-66.8%) | $4.42B(+9.4%) |
| Jun 2021 | - | $1.26B(-32.2%) | $4.04B(+13.9%) |
| Mar 2021 | $3.55B(+770.7%) | $1.86B(+110.0%) | $3.55B(+108.1%) |
| Dec 2020 | - | $884.69M(+2207.2%) | $1.71B(+224.7%) |
| Sep 2020 | - | $38.35M(-95.0%) | $525.12M(-53.0%) |
| Jun 2020 | - | $767.43M(+5127.0%) | $1.12B(+169.5%) |
| Mar 2020 | $407.36M(-66.6%) | $14.68M(-105.0%) | $414.98M(+208.4%) |
| Dec 2019 | - | -$295.34M(-146.8%) | $134.54M(-82.4%) |
| Sep 2019 | - | $631.66M(+887.3%) | $765.63M(+34.7%) |
| Jun 2019 | - | $63.98M(-124.1%) | $568.24M(-53.4%) |
| Mar 2019 | $1.22B(-27.7%) | -$265.76M(-179.2%) | $1.22B(+23.6%) |
| Dec 2018 | - | $335.76M(-22.7%) | $986.85M(-21.3%) |
| Sep 2018 | - | $434.26M(-39.3%) | $1.25B(+17.3%) |
| Jun 2018 | - | $715.28M(-243.5%) | $1.07B(-35.5%) |
| Mar 2018 | $1.68B(+57.9%) | -$498.44M(-182.7%) | $1.66B(-2.1%) |
| Dec 2017 | - | $602.52M(+141.5%) | $1.69B(+14.5%) |
| Sep 2017 | - | $249.46M(-80.9%) | $1.48B(+0.2%) |
| Jun 2017 | - | $1.30B(-382.1%) | $1.48B(+34.0%) |
| Mar 2017 | $1.07B(+53.4%) | -$462.50M(-219.4%) | $1.10B(-13.8%) |
| Dec 2016 | - | $387.44M(+57.0%) | $1.28B(-7.9%) |
| Sep 2016 | - | $246.83M(-73.5%) | $1.39B(-0.2%) |
| Jun 2016 | - | $929.84M(-425.6%) | $1.39B(+107.3%) |
| Mar 2016 | $695.17M(-153.4%) | -$285.55M(-157.4%) | $671.19M(-171.8%) |
| Dec 2015 | - | $497.19M(+98.8%) | -$934.54M(-26.1%) |
| Sep 2015 | - | $250.13M(+19.4%) | -$1.26B(+2.2%) |
| Jun 2015 | - | $209.43M(-111.1%) | -$1.24B(+11.4%) |
| Mar 2015 | -$1.30B(-219.0%) | -$1.89B(-1227.8%) | -$1.11B(-293.1%) |
| Dec 2014 | - | $167.69M(-39.6%) | $574.96M(-35.1%) |
| Sep 2014 | - | $277.40M(-17.5%) | $885.52M(-9.6%) |
| Jun 2014 | - | $336.05M(-263.0%) | $979.55M(+3.7%) |
| Mar 2014 | $1.09B(-39.8%) | -$206.18M(-143.1%) | $944.40M(-12.3%) |
| Dec 2013 | - | $478.25M(+28.8%) | $1.08B(+29.0%) |
| Sep 2013 | - | $371.44M(+23.4%) | $834.59M(-5.3%) |
| Jun 2013 | - | $300.90M(-505.8%) | $881.54M(-47.7%) |
| Mar 2013 | $1.82B | -$74.15M(-131.4%) | $1.68B(+29.0%) |
| Dec 2012 | - | $236.41M(-43.5%) | $1.31B(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $418.39M(-62.1%) | $1.40B(-20.6%) |
| Jun 2012 | - | $1.10B(-343.9%) | $1.77B(+10.2%) |
| Mar 2012 | $1.61B(-44.8%) | -$452.59M(-236.0%) | $1.60B(-34.6%) |
| Dec 2011 | - | $332.88M(-57.5%) | $2.45B(-18.3%) |
| Sep 2011 | - | $783.15M(-16.6%) | $3.00B(-5.4%) |
| Jun 2011 | - | $939.56M(+138.0%) | $3.17B(+7.8%) |
| Mar 2011 | $2.92B(-9.6%) | $394.75M(-55.2%) | $2.94B(-1.2%) |
| Dec 2010 | - | $881.86M(-7.6%) | $2.98B(+3.5%) |
| Sep 2010 | - | $954.40M(+34.2%) | $2.88B(+4.5%) |
| Jun 2010 | - | $711.36M(+65.3%) | $2.75B(-14.1%) |
| Mar 2010 | $3.23B(+37.1%) | $430.41M(-45.0%) | $3.21B(-7.9%) |
| Dec 2009 | - | $782.07M(-5.7%) | $3.48B(-6.3%) |
| Sep 2009 | - | $829.65M(-28.7%) | $3.71B(+5.1%) |
| Jun 2009 | - | $1.16B(+64.9%) | $3.53B(+47.0%) |
| Mar 2009 | $2.36B(-24.7%) | $705.23M(-30.5%) | $2.40B(+24.4%) |
| Dec 2008 | - | $1.02B(+56.1%) | $1.93B(+0.3%) |
| Sep 2008 | - | $650.47M(+1823.2%) | $1.93B(-4.6%) |
| Jun 2008 | - | $33.82M(-85.5%) | $2.02B(-34.2%) |
| Mar 2008 | $3.13B(+7.9%) | - | - |
| Mar 2008 | - | $233.69M(-76.8%) | $3.07B(-10.2%) |
| Dec 2007 | - | $1.01B(+35.7%) | $3.42B(+3.0%) |
| Sep 2007 | - | $743.48M(-31.3%) | $3.32B(+15.5%) |
| Jun 2007 | - | $1.08B(+85.7%) | $2.87B(-0.5%) |
| Mar 2007 | $2.90B(+3.8%) | - | - |
| Mar 2007 | - | $583.24M(-35.8%) | $2.89B(+12.0%) |
| Dec 2006 | - | $908.98M(+206.2%) | $2.58B(+2.5%) |
| Sep 2006 | - | $296.89M(-73.0%) | $2.52B(-10.4%) |
| Jun 2006 | - | $1.10B(+299.7%) | $2.81B(+1.0%) |
| Mar 2006 | $2.80B(+7.0%) | - | - |
| Mar 2006 | - | $274.70M(-67.5%) | $2.78B(-1.0%) |
| Dec 2005 | - | $845.88M(+43.8%) | $2.81B(+1.9%) |
| Sep 2005 | - | $588.31M(-45.0%) | $2.76B(-2.7%) |
| Jun 2005 | - | $1.07B(+251.9%) | $2.83B(+9.7%) |
| Mar 2005 | $2.61B(+2.4%) | - | - |
| Mar 2005 | - | $303.88M(-61.7%) | $2.58B(+13.3%) |
| Dec 2004 | - | $793.92M(+19.5%) | $2.28B(+53.5%) |
| Sep 2004 | - | $664.60M(-18.8%) | $1.48B(+81.2%) |
| Jun 2004 | - | $818.49M | $818.49M |
| Mar 2004 | $2.55B(+13.3%) | - | - |
| Mar 2003 | $2.25B(+17.9%) | - | - |
| Mar 2002 | $1.91B(+41.7%) | - | - |
| Mar 2001 | $1.35B(+23.6%) | - | - |
| Mar 2000 | $1.09B(+48.6%) | - | - |
| Mar 1999 | $732.88M(+8.0%) | - | - |
| Mar 1998 | $678.62M(+5.1%) | - | - |
| Mar 1997 | $645.81M(+2.1%) | - | - |
| Mar 1996 | $632.33M(+17.9%) | - | - |
| Mar 1995 | $536.17M(+17.8%) | - | - |
| Mar 1994 | $455.25M(+14.7%) | - | - |
| Mar 1993 | $397.06M(+49.9%) | - | - |
| Mar 1992 | $264.83M(-19.1%) | - | - |
| Mar 1991 | $327.28M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual net profit?
- What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly net profit?
- What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM net profit?
- What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
What is Takeda Pharmaceutical Company Limited annual net profit?
The current annual net income of TAK is $709.37M
What is the all time high annual net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual net profit is $3.55B
What is Takeda Pharmaceutical Company Limited annual net income year-on-year change?
Over the past year, TAK annual net profit has changed by -$287.83M (-28.86%)
What is Takeda Pharmaceutical Company Limited quarterly net profit?
The current quarterly net income of TAK is $860.12M
What is the all time high quarterly net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly net profit is $1.86B
What is Takeda Pharmaceutical Company Limited quarterly net income year-on-year change?
Over the past year, TAK quarterly net profit has changed by +$248.55M (+40.64%)
What is Takeda Pharmaceutical Company Limited TTM net profit?
The current TTM net income of TAK is $957.25M
What is the all time high TTM net income for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM net profit is $4.42B
What is Takeda Pharmaceutical Company Limited TTM net income year-on-year change?
Over the past year, TAK TTM net profit has changed by -$17.36M (-1.78%)